These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22995771)

  • 1. Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties.
    Rakesh ; Bruhn D; Madhura DB; Maddox M; Lee RB; Trivedi A; Yang L; Scherman MS; Gilliland JC; Gruppo V; McNeil MR; Lenaerts AJ; Meibohm B; Lee RE
    Bioorg Med Chem; 2012 Oct; 20(20):6063-72. PubMed ID: 22995771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis.
    Rakesh ; Bruhn DF; Scherman MS; Woolhiser LK; Madhura DB; Maddox MM; Singh AP; Lee RB; Hurdle JG; McNeil MR; Lenaerts AJ; Meibohm B; Lee RE
    PLoS One; 2014; 9(2):e87909. PubMed ID: 24505329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel isoxazolines as anti-tuberculosis agents.
    Tangallapally RP; Sun D; Rakesh ; Budha N; Lee RE; Lenaerts AJ; Meibohm B; Lee RE
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6638-42. PubMed ID: 17937983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent.
    Gallardo-Macias R; Kumar P; Jaskowski M; Richmann T; Shrestha R; Russo R; Singleton E; Zimmerman MD; Ho HP; Dartois V; Connell N; Alland D; Freundlich JS
    Bioorg Med Chem Lett; 2019 Feb; 29(4):601-606. PubMed ID: 30600207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agents.
    Budha NR; Mehrotra N; Tangallapally R; Rakesh ; Qi J; Daniels AJ; Lee RE; Meibohm B
    AAPS J; 2008; 10(1):157-65. PubMed ID: 18446516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
    Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
    Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
    Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents.
    Tangallapally RP; Yendapally R; Lee RE; Lenaerts AJ; Lee RE
    J Med Chem; 2005 Dec; 48(26):8261-9. PubMed ID: 16366608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
    Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
    Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents.
    Odingo J; O'Malley T; Kesicki EA; Alling T; Bailey MA; Early J; Ollinger J; Dalai S; Kumar N; Singh RV; Hipskind PA; Cramer JW; Ioerger T; Sacchettini J; Vickers R; Parish T
    Bioorg Med Chem; 2014 Dec; 22(24):6965-79. PubMed ID: 25456390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
    Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K
    Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents.
    Tao X; Gao C; Huang ZG; Luo W; Liu KL; Peng CT; Ding CZ; Li J; Chen SH; Yu LT
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2511-2515. PubMed ID: 31353295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents.
    Elsaman T; Mohamed MS; Mohamed MA
    Bioorg Chem; 2019 Jul; 88():102969. PubMed ID: 31077910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
    Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
    North EJ; Scherman MS; Bruhn DF; Scarborough JS; Maddox MM; Jones V; Grzegorzewicz A; Yang L; Hess T; Morisseau C; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2013 May; 21(9):2587-99. PubMed ID: 23498915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
    Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
    J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
    Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A
    Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents.
    Rakesh ; Sun D; Lee RB; Tangallapally RP; Lee RE
    Eur J Med Chem; 2009 Feb; 44(2):460-72. PubMed ID: 18524421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.